The Biotech Growth Trust PLC reported earnings results for the full year ended March 31, 2023. For the full year, the company reported net loss was GBP 41.3 million compared to GBP 202.42 million a year ago. Basic loss per share from continuing operations was GBP 1.025 compared to GBP 4.885 a year ago.

Diluted loss per share from continuing operations was GBP 1.025 compared to GBP 4.885 a year ago.